과제정보
본 논문은 2022년도 (주)에이피테크놀로지(수원, 대한민국)로부터 시험물질과 연구비(세부과제번호: ERT2111290) 지원에 의해 수행되었으며, 이에 감사드립니다.
참고문헌
- Andrews CN, Storr M. 2011. The pathophysiology of chronic constipation. Can J Gastroenterol 25:169319
- Ballard O, Morrow AL. 2013. Human milk composition: Nutrients and bioactive factors. Pediatr Clin North Am60:49-74 https://doi.org/10.1016/j.pcl.2012.10.002
- Bode L. 2012. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 22:1147-1162 https://doi.org/10.1093/glycob/cws074
- Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR. 2004. The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 80:1658-1664 https://doi.org/10.1093/ajcn/80.6.1658
- Bourlioux P, Koletzko B, Guarner F, Braesco V. 2003. The intestine and its microflora are partners for the protection of the host: Report on the Danone Symposium "The Intelligent Intestine," held in Paris. Am J Clin Nutr 78:675-683 https://doi.org/10.1093/ajcn/78.4.675
- Deutsch L, Stres B. 2021. The importance of objective stool classification in fecal 1H-NMR metabolomics: Exponential increase in stool crosslinking is mirrored in systemic inflammation and associated to fecal acetate and methionine. Metabolites 11:172
- Elison E, Vigsnaes LK, Krogsgaard LR, Rasmussen J, Sorensen N, McConnell B, Hennet T, Sommer MOA, Bytzer P. 2016. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. Br J Nutr 116:1356-1368 https://doi.org/10.1017/S0007114516003354
- Facinelli B, Marini E, Magi G, Zampini L, Santoro L, Catassi C, Monachesi C, Gabrielli O, Coppa GV. 2019. Breast milk oligosaccharides: Effects of 2'-fucosyllactose and 6'-sialyllactose on the adhesion of Escherichia coli and Salmonella fyris to Caco-2 cells. J Matern Fetal Neonatal Med 32:2950-2952 https://doi.org/10.1080/14767058.2018.1450864
- Farhin S, Wong A, Delungahawatta T, Amin JY, Bienenstock J, Buck R, Kunze WA. 2019. Restraint stress induced gut dysmotility is diminished by a milk oligosaccharide (2'-fucosyllactose) in vitro. PLOS ONE 14:e0215151
- Fiordaliso M, Kok N, Desager JP, Goethals F, Deboyser D, Roberfroid M, Delzenne N. 1995. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30:163-167 https://doi.org/10.1007/BF02538270
- German JB, Freeman SL, Lebrilla CB, Mills, DA. 2008. Human milk oligosaccharides: evolution, structures and bioselectivity as substrates for intestinal bacteria. Nestle Nutr Workshop Ser Pediatr Program 62:205-222 https://doi.org/10.1159/000146322
- Gevers D, Knight R, Petrosino JF, Huang K, McGuire AL, Birren BW, Nelson KE, White O, Methe BA, Huttenhower C. 2012. The human microbiome project: A community resource for the healthy human microbiome. PLOS Biol 10:e1001377
- Gibson GR, Wang X. 1994. Regulatory effects of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412-420 https://doi.org/10.1111/j.1365-2672.1994.tb03443.x
- Gibson GR. 1999. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 129:1438S-1441S https://doi.org/10.1093/jn/129.7.1438S
- Good M, Sodhi CP, Yamaguchi Y, Jia H, Lu P, Fulton WB, Martin LY, Prindle T Jr, Nino DF, Zhou Q, Ma C, Ozolek JA, Buck RH, Goehring KC, Hackam DJ. 2016. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine. Br J Nutr116:1175-1187
- Han NS, Kim TJ, Park YC, Kim J, Seo JH. 2012. Biotechnological production of human milk oligosaccharides. Biotechnol Adv 30:1268-1278 https://doi.org/10.1016/j.biotechadv.2011.11.003
- Kim BS. 2023. Human Stool image analysis based on deep learning for smart home healthcare system. Ph.D. Thesis, Pukyoung National Univ. Busan. Korea
- Kleessen B, Stoof G, Proll J, Schmiedl D, Noack J, Blaut M. 1997. Feeding resistant starch affects fecal and cecal microflora and short-chain fatty acids in rats. J Anim Sci 75:2453-2462 https://doi.org/10.2527/1997.7592453x
- Kulinich A, Liu L. 2016. Human milk oligosaccharides: The role in the fine-tuning of innate immune responses. Carbohydr Res 432:62-70 https://doi.org/10.1016/j.carres.2016.07.009
- Kwon Y, Lee S. 2002. Effects of Bifidobacteriaand oligosaccharides on the quality attributes of frozen soy yogurts. Korean J Soc Food Cookery Sci 18:43-50
- Lee G, Park SS, Lee WC. 1996. A study on the Han, fecal, and urine in Sasang constitutional medicine. Korean J Orient Int Med 17:123-138
- Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, Van Tassell ML, Miller MJ, Jin YS, German JB, Lebrilla CB, Mills DA. 2015. Maternal fucosyltransferase2 status affects the gut bifidobacterial communities of breastfed infants. Microbiome 3:13
- Maloy KJ, Powrie F. 2011. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474: 298-306 https://doi.org/10.1038/nature10208
- Mao B, He Z, Chen Y, Stanton C, Ross RP, Zhao J, Chen W, Yang B. 2022. Effects of Bifidobacterium with the ability of 2'-fucosyllactose utilization on intestinal microecology of mice. Nutrients 14:5392
- Marriage BJ, Buck RH, Goehring KC, Oliver JS, Williams JA. 2015. Infants fed a lower calorie formula with 2'FL show growth and 2'FL uptake like breast-fed infants. J Pediatr Gastroenterol Nutr 61:649-658 https://doi.org/10.1097/MPG.0000000000000889
- Martinez-Ferez A, Rudloff S, Guadix A, Henkel CA, Pohlentz G, Boza JJ, Guadix EM, Kunz C. 2006. Goats' milk as a natural source of lactose-derived oligosaccharides: Isolation by membrane technology. Int Dairy J 16:173-181 https://doi.org/10.1016/j.idairyj.2005.02.003
- Matsuda K, Akiyama T, Tsujibe S, Oki K, Gawad A, Fujimoto J. 2021. Direct measurement of stool consistency by texture analyzer and calculation of reference value in Belgian general population. Sci Rep 11:2400
- Matsuki T, Yahagi K, Mori H, Matsumoto H, Hara T, Tajima S, Ogawa E, Kodama H, Yamamoto K, Yamada T, Matsumoto S, Kurokawa K. 2016. A key genetic factor for fucosyllactose utilization affects infant gut microbiota development. Nat Commun 7:11939
- Ministry of Food and Drug Safety. 2020. Functional evaluation guideline of health functional food. Available from https://www.mfds.go.kr/brd/m_1060/view.do?seq=14660&srchFr=&srchTo=&srchWord=%EC%9E%A5+%EA%B1%B4%EA%B0%95&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1 [cited 22 June 2023]
- Morrow AL, Ruiz-Palacios GM, Altaye M, Jiang X, Guerrero ML, Meinzen-Derr JK, Farkas T, Chaturvedi P, Pickering LK, Newburg DS. 2004. Human milk oligosaccharide blood group epitopes and innate immune protection against Campylobacter and calicivirus diarrhea in breastfed infants. In Pickering LK, Morrow AL, Ruiz-Palacios GM, Schanler RJ (Eds.), Protecting Infants through Human Milk. Advancing the Scientific Evidence, Vol. 554. pp.443-446. Springer
- Na MH, Kim WK. 2007. Effects of xylooligosaccharide intake on fecal Bifidobacteria, lactic acid and lipid metabolism in Korean young women. J Nutr Health 40:154-161
- Newburg DS, Ruiz-Palacios GM, Altaye M, Chaturvedi P, Lourdes Guerrero M, Meinzen-Derr JK, Morrow AL. 2004. Human milk α1,2-linked fucosylated oligosaccharides decrease risk of diarrhea due to stable toxin of E. coli in breastfed infants. In Pickering LK, Morrow AL, Ruiz-Palacios GM, Schanler RJ (Eds.), Protecting Infants through Human Milk. Advancing the Scientific Evidence, Vol. 554. pp.457-461. Springer
- Ninonuevo M, An H, Yin H, Killeen K, Grimm R, Ward R, German B, Lebrilla C. 2005. Nanoliquid chromatography-mass spectrometry of oligosaccharides employing graphitized carbon chromatography on microchip with a high-accuracy mass analyzer. Electrophoresis 26:3641-3649 https://doi.org/10.1002/elps.200500246
- Ogata T, Nakamura T, Anjitsu K, Yaeshima T, Takahashi S, Fukuwatari Y, Ishibashi N, Hayasawa H, Fujisawa T, Iino H. 1997. Effect of Bifidobacterium longumBB536 administration on the intestinal environment, defecation frequency and fecal characteristics of human volunteers. Biosci Microflora 16:53-58 https://doi.org/10.12938/bifidus1996.16.53
- Ramirez-Farias C, Baggs GE, Marriage BJ. 2021. Growth, tolerance, and compliance of infants fed an extensively hydrolyzed infant formula with added 2'-FL fucosyllactose (2'-FL) human milk oligosaccharide. Nutrients 13:186
- Rho JH, Kim MH. 2011. Foods, digesting and absorbing. Bull Food Technol 24:498-524
- Robinson RR, Feirtag J, Slavin JL. 2001. Effects of dietary arabinogalactan on gastrointestinal and blood parameters in healthy human subjects. J Am Coll Nutr 20:279-285 https://doi.org/10.1080/07315724.2001.10719048
- Ruiz-Palacios GM, Cervantes LE, Ramos P, Chavez-Munguia B, Newburg DS. 2003. Campylobacter jejuni binds intestinal H(O) antigen (Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J Biol Chem 278:14112-14120 https://doi.org/10.1074/jbc.M207744200
- Sharma A, Rao S. 2017. Constipation: Pathophysiology and current therapeutic approaches. In Greenwood-Van Meerveld B (Ed.), Gastrointestinal Pharmacology. Handbook of Experimental Pharmacology, Vol. 239. pp.59-74. Springer
- Smith-Brown P, Morrison M, Krause L, Davies PSW. 2016. Mothers secretor status affects development of childrens microbiota composition and function: A pilot study. PLOS ONE 11:e0161211
- Soyyilmaz B, Miks MH, Rohrig CH, Matwiejuk M, Meszaros-Matwiejuk A, Vigsnaes LK. 2021. The mean of milk: A review of human milk oligosaccharide concentrationsthroughout lactation. Nutrients 13:2737
- Tateyama I, Hashii K, Johno I, Iino T, Hirai K, Suwa Y, Kiso Y. 2005. Effect of xylooligosaccharide intake on severe constipation in pregnant women. J Nutr Sci Vitaminol 51:445-448 https://doi.org/10.3177/jnsv.51.445
- Thongaram T, Hoeflinger JL, Chow J, Miller MJ. 2017. Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. J Dairy Sci 100:7825-7833 https://doi.org/10.3168/jds.2017-12753
- Vazquez E, Barranco A, Ramirez M, Gruart A, Delgado-Garcia JM, Martinez-Lara E, Blanco S, Martin MJ, Castanys E, Buck R, Prieto P, Rueda R. 2015. Effects of a human milk oligosaccharide, 2'-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. J Nutr Biochem 26:455-465 https://doi.org/10.1016/j.jnutbio.2014.11.016
- Vivatvakin B, Mahayosnond A, Theamboonlers A, Steenhout PG, Conus N. 2010. Effect of a whey-predominant starter formula containing LCPUFAs and oligosaccharides (FOS/GOS) on gastrointestinal comfort in infants. Asia Pac J Clin Nutr 19:473-480
- Wang L, Hu L, Yan S, Jiang T, Fang S, Wang G, Zhao J, Zhang H, Chen W. 2017. Effects of different oligosaccharides at various dosages on the composition of gut microbiota and short-chain fatty acids in mice with constipation. Food Funct 8:1966-1978 https://doi.org/10.1039/C7FO00031F
- Wheeler RR, Katzmann RA. 2006. A primer on interbranch relations. Geo L J 95:1155
- Yu ZT, Nanda Nanthakumar N, Newburg DS. 2016. The human milk oligosaccharide 2'-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa. J Nutr146:1980-1990
- Zehra S, Khambati I, Vierhout M, Firoz Mian M, Buck R, Forsythe P. 2018. Human milk oligosaccharides attenuate antigen-antibody complex induced chemokine release from human intestinal epithelial cell lines. J Food Sci 83:499-508 https://doi.org/10.1111/1750-3841.14039
- Zuckerman GR, Trellis DR, Sherman TM, Clouse RE. 1995. An objective measure of stool color for differentiating upper from lower gastrointestinal bleeding. Dig Dis Sci 40:1614-1621 https://doi.org/10.1007/BF02212679